Deutsche Bank Aktiengesellschaft Raises CME Group (NASDAQ:CME) Price Target to $310.00

CME Group (NASDAQ:CME) had its price objective increased by analysts at Deutsche Bank Aktiengesellschaft from $300.00 to $310.00 in a research report issued to clients and investors on Friday,MarketScreener reports. The brokerage currently has a “buy” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of 9.65% from the stock’s previous close.

CME has been the subject of a number of other reports. Oppenheimer boosted their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Barclays lowered their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 8th. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. The Goldman Sachs Group boosted their price objective on shares of CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research report on Thursday, October 23rd. Finally, Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $287.65.

CME Group Price Performance

NASDAQ CME traded down $0.81 on Friday, hitting $282.73. The stock had a trading volume of 1,384,408 shares, compared to its average volume of 2,199,924. The firm has a 50-day moving average of $266.87 and a 200-day moving average of $272.73. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 52-week low of $222.56 and a 52-week high of $290.79. The company has a market capitalization of $101.95 billion, a price-to-earnings ratio of 27.37, a price-to-earnings-growth ratio of 4.41 and a beta of 0.38.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the company posted $2.68 earnings per share. The business’s revenue was down 3.0% on a year-over-year basis. Equities analysts expect that CME Group will post 10.49 EPS for the current year.

Insiders Place Their Bets

In other news, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This represents a 3.83% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 14,043 shares of company stock worth $3,791,486. Corporate insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Large investors have recently made changes to their positions in the business. Webster Bank N. A. boosted its stake in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares during the period. Caldwell Trust Co lifted its holdings in shares of CME Group by 116.3% during the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after buying an additional 50 shares during the last quarter. Highline Wealth Partners LLC raised its stake in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of CME Group in the third quarter valued at $27,000. Finally, Financial Consulate Inc. bought a new stake in shares of CME Group during the third quarter valued at approximately $28,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.